Portet Sur Garonne, France

Peter Keane

This inventor holds 3 USPTO granted patents. Top assignees: Elf Sanofi, Sanofi Sa. Active years: 1988-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Toulouse, FR (1988)
  • Portet Sur Garonne, FR (1994 - 1995)

Company Filing History:


Years Active: 1988-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Peter Keane

Introduction

Peter Keane is a notable inventor based in Portet Sur Garonne, France. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 3 patents to his name, his work continues to influence various applications in the industry.

Latest Patents

Among his latest patents, Peter has developed a compound known as Heterocycle-coupled substituted pyrrolo[3,2-c]pyridin-2-carboxylic acids. This compound features a complex formula where A represents S, and R groups are selected from a variety of functional groups, including OH, (C1-C12)alkyl, and phenyl. Another significant patent involves substituted thienyl- or pyrrolylcarboxyclic acid derivatives, showcasing his expertise in creating innovative chemical structures.

Career Highlights

Throughout his career, Peter has worked with prominent companies such as Elf Sanofi and Sanofi SA. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical and chemical sectors.

Collaborations

Peter has collaborated with esteemed colleagues, including Etienne Mendes and Jean-Claude Vernieres. These partnerships have fostered a creative environment that has led to the development of innovative solutions in their respective fields.

Conclusion

Peter Keane's journey as an inventor is marked by his dedication to innovation and collaboration. His contributions to the field of chemistry through his patents and professional experiences continue to pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…